The Recovery of Cardiovascular Patients With Depression
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
Cardiovascular disease increases the risk of depression and vice versa. Many cardiovascular
patients are subjected to percutaneous coronary intervention (PCI). Potential biomarkers for
the development, the course and the recovery of both diseases are in the focus of interest of
many studies. One of the biomarkers that stands out is brain derived neurotrophic factor
(BDFN). BDNF plays a significant role in regulating vascular growth and repair but also
stimulates the survival, differentiation, and conservation of neurons.
The aim of the study is to detect the depression in patients undergoing PCI and to determine
the impact of psychiatric treatment on the functional recovery and on the changes of BDNF.